Daily Equity Report 15 May 2019

1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 15 THMAY 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET CLOSE PREVIOUS ! INDIANEQUITYBENCHMARK- Benchmarkindicesclosed in the green after falling for nine consecutive sessions. Sensexwasup227pointsat37,318.53,whileNiftyclosedat NIFTY 11,222,up73.80points.About1223shareshaveadvanced, CLOSE PREVIOUS 1260shareshavedeclined,and132sharesareunchanged. NIKKEI SunPharma,BhartiAirtel,IndiabullsHousingandVedanta wereamongtopindexgainers,whileTCS,TechMahindra, HCL Technologies and Bajaj Finance were among the top 2081.84 2079.01 losersontheindex.ExceptITthatfellover1percent,all SECTORIAL INDICES sectoralindicesweretradinginthegreen.PSUBankisthe CLOSE CHANGE (%) biggestgainer,surgingabout3 percent.NiftyMidcap100 CNX 100 0.61 wasup80pointsat16737.25,whileNiftySmallcap100was S&P CNX 500 9212.35 0.57 at6,142.80,up43points. GLOBALFACE 4622.05 0.72 CNX 200 5806.90 0.59 ! BANK NIFTY 0.59 AsianMarket- Asianmarketsfinishedbroadlylowertoday withsharesinHongKongleadingtheregion.TheHangSeng isdown1.50%whileChina'sShanghaiCompositeisoff0.69% TOP GAINERS andJapan'sNikkei225islowerby0.59%. CLOSE 6.49 ! U.S.Market– NorthandSouth Americanmarketsfinished broadlyloweronMondaywithsharesinBrazilleadingthe region.TheBovespaisdown2.69%whileU.S.'sS&P500isoff BHARTIARTL 6.07 SUNPHARMA 5.63 2.41%andMexico'sIPCislowerby0.55%. 4.64 ! TOP LOSERS Europeanmarkets– Europeanmarketsarebroadlyhigher today withsharesinFranceleadingtheregion.TheCAC40is CLOSE CHANGE (%) up1.07%whileLondon'sFTSE100isup0.84%and Germany'sDAXisup0.46%. TECHM BAJFINANCE 2,885.75 -1.57 2,095.80 -1.55 1,067.15 -1.52 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE TREND STRATEGY SCRIPT CLOSE (%) 6.49 PIVOT POINTS 3.82 S3 10835 S2 11021 R1 11308 R2 11394 R3 11581 GAIL 11121 11208 2.97 S1-11100 S2-11010 R1-11355 R2-11470 2.84 MARKET MOVERS DOWNSIDE CLOSE (%) -3.08 -0.85 INFY ASIANPAINT -0.56 -0.49 M&M NET BUY (CR.) NET STRATEGY SELL ON RISE SELL (CR) 2972.22 PIVOT POINTS P 28962 S1 28727 R1 29225 R2 R3 29958 DII 3847.54 27966 28464 29460 RESISTANCE NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY 3 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! ! SiemensPATup27.6%yoyatRs280cr inQ2FY19 KarnatakaBanksQ4FY19PATat Rs477.24cr KarnatakaBankpostedanall-timehighannualnetprofit of Rs477.24cr for the FY19, with a growth rate of 46.57%.Theprevious highest netprofit ofRs452.26cr was posted during the year 2016-17. The Non- Performing Assets (NPA) also moderated. The GNPA [GrossNon-PerformingAssets]oftheBankdeclinedto 4.41%asofMarch31,2019,from4.92%asonMarch31, 2018.Similarly,theNNPA(NetNon-PerformingAssets) alsomoderatedto2.95%from2.96%asonMarch31, 2018. SiemensrecordedaProfitafterTax(PAT)forthesecond quarter of Financial Year 2019 at Rs280cr, which is increased by 27.6% over the same period last year. Revenue stood at Rs3, 461cr, a 9.4% increase over the correspondingquarterofthepreviousyear,thecompany said in the filing to the exchanges on Tuesday. The companysnewordersforthequarterstoodatRs3,635cr, a24.3%increaseoverthesecondquarterofFinancialYear 2018.Orderbacklogrecordedasix-yearhigh. ! LupinreceivesEIRforPharmacovigilance inspection LupininitsfilingtotheexchangesonTuesdayinformed thatthecompanyhasreceivedtheEstablishment InspectionReport(EIR)fromtheUnitedStatesFoodand DrugAdministration(USFDA)forthePost-Marketing AdverseDrugExperience(PADE)inspection,indicating successfulclosureoftheinspection.Theinspectionwas conductedatLupin'sglobalpharmacovigilancegroup DSRM(DrugSafety&RiskManagement)basedoutof MumbaibetweenJanuary14,2019,andJanuary 18,2019, thecompanysaidinapressnotetoday. ! GlenmarkgetsUSFDAnodfor EsomeprazoleMagnesiumDRcapsules GlenmarkPharmaceuticalsInc.,USA(Glenmark)hasbeen grantedfinalapprovalbytheUnitedStatesFood&Drug Administration(USFDA)forEsomeprazoleMagnesiumDelayed- ReleaseCapsulesUSP,20mgand40mg,agenericversionof NexiumDelayed-ReleaseCapsules,20mgand40mg,of AstraZenecaPharmaceuticalsLP.AccordingtoIQVIAsalesdata forthe12-monthperiodendingMarch2019,theNexium Delayed-ReleaseCapsules,20mgand40mgmarket2achieved annualsalesofapproximately$395.1million.Glenmarkscurrent portfolioconsistsof153productsauthorizedfordistributionin theU.S.marketplaceand58ANDAspendingapprovalwiththe USFDA. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NAME OF THE STOCK : SRF DATE : 15/05/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENTADVICE: CALLCS CALL:- BUY SRF IN CASH ABOVE 2600 TGT 2660 SL 2550 RATIONALEFORARRIVINGINVESTMENTADVICE: TECHNICALVIEW: THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.